期刊文献+

真菌黑色素辐射防护作用综述 被引量:4

Progress in fungi melanin radioprotection
下载PDF
导出
摘要 从电子转移和能量传递作用、自由基清除作用、金属螯合作用及光保护作用等方面总结了近年来对真菌黑色素辐射防护作用机制的研究进展。在未来研究中,真菌黑色素二级结构的确定,能量传递作用以及在生物体内的辐射防护作用将成为其研究的突破方向。 The progress of fungal melanins' radioprotection mechanism was summarized in four aspects: electron transfer and energy transmission, radicals scavenging, binding of metals, and photoprotection. The breakthrough in the future research will be focused on the determination of secondary structure, the energy transfer effect, and the radioprotection in organism.
出处 《辐射研究与辐射工艺学报》 CAS CSCD 2016年第6期1-6,共6页 Journal of Radiation Research and Radiation Processing
基金 "西部之光"一般项目(2011)资助~~
关键词 黑色素 真菌 辐射防护 Melanin, Fungi, Radiation protection
  • 相关文献

参考文献1

二级参考文献41

  • 1Bodenham D C. A study of 650 observed malignant melanomas in the South-West region[J]. Annals of the Royal College of Surgeons of England, 1968, 43(4): 218-239.
  • 2Yang A, Chapman P. The history and future of chemotherapy for melanoma [J]. Hamatology/Oneology Clinics of N America, 2009, 23(3): 583-597.
  • 3Korn E L, Liu P Y, Lee S J, et al. Meta-analysis of phase II cooperative group trials in metastatie stage IV melanoma to determine progression- free and overall survival benchmarks for future phase II trials[J]. Journal of clinical oneology: Official Journal of the American Soeiety of Clinical Oneology, 2008, 26(4): 527-534.
  • 4Atkins M B, Lotze M T, Duteher J P, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993[J]. Journal of Clinical Oneology: Offieial Journal of the American Soeiety of Clinieal Oneology, 1999, 17(7): 2105-2116.
  • 5Kirkwood J M, Manola J, Ibrahim J, et al. A pooled analysis of eastern eooperative oneology group and intergroup trials of adjuvant high-dose interferon for melanoma[J]. Clinical Caneer Research, 2004, 10(5): 1670-1677.
  • 6Dong J, Phelps R G, Qiao R, et al. BRAF oneogenie mutations correlate with progression rather than initiation of human melanoma[J]. Caneer Research, 2003, 63(14): 3883-3885.
  • 7Chapman P B, Hausehild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation[J]. New England Journal of Medicine, 2011,364(26): 2507-2516.
  • 8Si L, Kong Y, Xu X, et al. Prevalence of BRAFvrE mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-ease cohort[J]. European Journal of Caneer, 2012, 48(1): 94- 100.
  • 9Hausehild A, Grob J J, Demidov L V, et al. Dabrafenib in BRAF- mutated metastatie melanoma: A multieentre, open-label, phase 3 randomised controlled trial[J]. Lancet, 2012, 380(9839): 358-365.
  • 10Sosman J A, Kim K B, Sehuehter L, et al. Survival in BRAF V600- mutant advanced melanoma treated with vemurafenih[J]. New England Journal of Medicine, 2012, 366(8): 707-714.

共引文献13

同被引文献48

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部